AB0280 SURVIVAL ANALYSIS ON SECOND BIOLOGIC THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS OLDER THAN 65 YEARS

MLA

Andrea Briones-Figueroa, et al. “Ab0280 Survival Analysis on Second Biologic Therapy in Patients with Rheumatoid Arthritis Older Than 65 Years.” Annals of the Rheumatic Diseases, vol. 79, June 2020, p. 1439.2-1439. EBSCOhost, https://doi.org/10.1136/annrheumdis-2020-eular.4911.

APA

Andrea Briones-Figueroa, M. Vázquez Díaz, J. Bachiller-Corral, M. Tortosa-Cabañas, B. A. Blanco Cáceres, & J.L. Morell Hita. (2020). Ab0280 Survival Analysis on Second Biologic Therapy in Patients with Rheumatoid Arthritis Older Than 65 Years. Annals of the Rheumatic Diseases, 79, 1439.2-1439. https://doi.org/10.1136/annrheumdis-2020-eular.4911

Chicago

Andrea Briones-Figueroa, M. Vázquez Díaz, J. Bachiller-Corral, M. Tortosa-Cabañas, B. A. Blanco Cáceres, and J.L. Morell Hita. 2020. “Ab0280 Survival Analysis on Second Biologic Therapy in Patients with Rheumatoid Arthritis Older Than 65 Years.” Annals of the Rheumatic Diseases 79 (June): 1439.2-1439. doi:10.1136/annrheumdis-2020-eular.4911.